← Back to Clinical Trials
Recruiting NCT05447338

NCT05447338 Manual Therapy in Patients With Neck Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05447338
Status Recruiting
Phase
Sponsor Universidad Nacional de Córdoba
Condition Neck Pain
Study Type INTERVENTIONAL
Enrollment 114 participants
Start Date 2021-08-30
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
Specific joint mobilization post muscle inhibition on C1Maitland C2SNAG C1

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 114 participants in total. It began in 2021-08-30 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Neck pain is a common clinical condition of some diseases that affect the soft tissues, musculotendinous structures and joints of the cervical spine. It is characterized by pain in the posterior and lateral muscles of the neck, muscle contractures and partial functional impotence. An important finding is that approximately 60% of total cervical rotation takes place at C1-C2, regardless of age. The test used to diagnose dysfunction of the upper cervical spine is the Cervical Rotation Flexion Test (CRFT) and is measured in degrees through various instruments, the most current validated by scientific literature are mobile applications (Clinometer and Compass ). Having in clear the importance of the location (C1-C2) of the origin of many of the symptoms and signs that cervicalgia generates and mainly the restriction of the range of movement that they produce in the cervical spine. It is that the manual therapy technique: Joint mobilization post muscular inhibition (MAEPI) that is included in this study for its analysis, is directed to this segment of the cervical spine. This differs from other similar techniques, in terms of location and movement of the joint surfaces, which have been previously studied and have shown their effectiveness (techniques that will be used in the control group), in that the micro movements of the joint surfaces ( joint arthrokinematics) based on the principles of Kaltenborn-Evjenth will be combined with the principles of the hold relax technique belonging to the Proprioceptive Neuromuscular Facilitation method. The main therapeutic objective of the MAEPI technique is to improve mobility and reduce pain in the cervical spine. Hypothesis: The MAEPI technique will improve mobility and reduce neck pain as well as other symptoms associated with neck pain, such as headache, dizziness and nausea, and will be more effective than those of the control group (Maitland central posterior-anterior passive joint mobilization in C2 and natural apophyseal slippage sustained (SNAG) in rotation about Mulligan's C1). The MAEPI technique will be more effective when applied later to myofascial induction techniques.

Eligibility Criteria

Inclusion criteria: * You must have a medical indication for cervical physiotherapy. * Must present decreased ROM of the upper cervical spine assessed with CRFT, either acute or subacute and of a mechanical type or PN and grade I and II of severity according to The Neck Pain Task Force. Exclusion criteria: * Joint instability, dislocations, fractures or stenosis of the cervical spinal canal. * Malformations and/or bony alterations of the cervical spine or the brain. * Head injury or whiplash in the last 10 years. Infections, unhealed wounds, tumors, vascular pathology or cancer that compromises the cervical spine and/or the brain. * Being under treatment with anti-inflammatories, muscle relaxants or some type of pain reliever.

Contact & Investigator

Central Contact

Franco Catelotti

✉ franco.catelotti@outlook.com

📞 3516640194

Principal Investigator

Franco Catelotti

PRINCIPAL INVESTIGATOR

Universidad Nacional de Córdoba; Argentina

Frequently Asked Questions

Who can join the NCT05447338 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 50 Years, studying Neck Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05447338 currently recruiting?

Yes, NCT05447338 is actively recruiting participants. Contact the research team at franco.catelotti@outlook.com for enrollment information.

Where is the NCT05447338 trial being conducted?

This trial is being conducted at Córdoba, Argentina.

Who is sponsoring the NCT05447338 clinical trial?

NCT05447338 is sponsored by Universidad Nacional de Córdoba. The principal investigator is Franco Catelotti at Universidad Nacional de Córdoba; Argentina. The trial plans to enroll 114 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology